Daily Equity Reports 03 July 2019

1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 03 RDJULY 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! 39686.50 INDIAN EQUITY BENCHMARK - Benchmark indices closed higher for second consecutive session on optimism ahead of Budget 2019 scheduled to be presented later this week. The NIFTY 11865.60 Sensex gained 129.98 points to close at 39,816.48 and the CLOSE PREVIOUS Nifty50 climbed 44.70 points to 11,910.30 but the market NIKKEI 21729.97 breadth was balanced. About 1,135 shares advanced against 1,327 declining shares on the BSE. Among Sensex 30 stocks, 28542.62 ONGC, HDFC, Bharti Airtel, Coal India and Infosys rallied 1-3 2122.02 percent whereas Yes Bank plunged 8.2 percent. Sun Pharma, SECTORIAL INDICES Tata Motors, Bajaj Auto and IndusInd Bank were down 1-2.6 CLOSE CHANGE (%) percent. Adani Power, UPL, Tata Power, Torrent Power and CNX 100 Reliance Infrastructure were top gainers among midcaps S&P CNX 500 while Bayer Crop Science, Oberoi Realty, MphasiS, Vakrangee and Kansai Nerolac were top losers. GLOBAL FACE CNX 200 BANK NIFTY 31283.30 ! Asian Market - Asian markets finished mixed as of the most recent closing prices. The Hang Seng gained 1.08% and the TOP GAINERS CLOSE CHANGE (%) Nikkei 225 rose 0.11%. The Shanghai Composite lost 0.03%. UPL 655.85 ! U.S. Market – North and South American markets finished higher on Monday with shares in U.S. leading the region. The S&P 500 is up 0.77% while Mexico's IPC is up 0.64% and 165.80 639.55 Brazil's Bovespa is up 0.37%. IOC 154.70 ! TOP LOSERS European markets – European markets are higher today with shares in London leading the region. The FTSE 100 is up CLOSE CHANGE (%) 0.60% while France's CAC 40 is up 0.07% and Germany's DAX is up 0.01%. YESBANK 100.10 -2.68 SUNPHARMA -2.63 -1.01 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NIFTY SPOT MARKET MOVERS UPSIDE TREND STRATEGY BUY ON DIPS SCRIPT CLOSE (%) PIVOT POINTS S3 11675 S2 11778 R1 11946 R2 11983 RESISTANCE R1-12020 R2-12150 R3 12086 HDFC 11844 11880 SUPPORT S1-11800 S2-11645 COALINDIA MARKET MOVERS DOWNSIDE CLOSE (%) -8.29 -0.97 AXISBANK ZEEL -0.95 -0.89 ASIANPAINT NET BUY (CR.) NET SELL (CR) STRATEGY BUY ON DIPS 3247.54 BULLISH PIVOT POINTS P 31364 DII 2328.04 S1 31199 R1 31553 R2 R3 32071 NSE TOTALS ADVANCE 30658 31011 31718 RESISTANCE BANK NIFTY S NIFTY BANK NIFTY 8 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report MARKET TALKS ! for ERP! Ramco Systems selected project by Erickson Alembic Pharma receives USFDA nod for Febuxostat tablets Alembic Pharmaceuticals has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Febuxostat Tablets, 40 mg and 80 mg. The approved ANDA is therapeutically equivalent to the: reference listed drug (RLD), Uloric Tablets, 40 mg and 80 mg, of Takeda Pharmaceuticals USA., Inc. (Takeda). Febuxostat Tablets are xanthine oxidase (XO) inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable. Shares of Ramco Systems traded 3% higher following the news that Erickson Incorporated has selected the company to implement its Aviation M&E MRO Solution V5.8. Ericksons advanced enterprise solutions integration will link all Maintenance, Supply Chain Management, Safety & Quality, Flight Operations, MRO Sales, and Manufacturing functions into a single system. Modules will include EFB (electronic flight bag), Mobility, Optimization Solution, Hubs, Dashboards and Chatbot. ! HCL Tech completes acquisition of select IBM products HCL Technologies on July 1 announced the completion of the planned acquisition of select IBM products for security, marketing, commerce, and December, HCL Technologies had announced that it would acquire select IBM software products for $1.8bn (Rs12, 700cr) in an all-cash deal. "As part of the deal's close, HCL takes full ownership of the research and development, sales, marketing, delivery, and support for AppScan, BigFix, Commerce, Connections, Digital Experience (Portal and Content Manager), Notes Domino, and Unica," HCL said in a statement to the exchanges. digital solutions. Last ! JSW Energy's planned acquisition of Jindal Steel plant terminated Shares of JSW Energy rose 3% in todays trade after the company aborted its plan to acquire the 1000MW (4x250 MW) thermal power plant located at Village Tamnar, District Raigarh in the state of Chhattisgarh from Jindal Steel and Power Limited. Further, vide letter dated 28th June 2018, we had informed you that as the conditions precedent were yet to be completed, it was decided to extend the Long Stop Date from June 30, 2018, to June 30, 2019," the company said. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NAME OF THE STOCK : SBILIFE DATE : 03/07/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENT ADVICE: CALL CS CALL:- BUY SBILIFE IN CASH ABOVE 750 TGT 765 SL 735 RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. CapitalStars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. CapitalStars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Intraday stock tips Financial advisory company Sharemarket company Stock Tips * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

8. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.